Search

Your search keyword '"Kunnumakkara AB"' showing total 192 results

Search Constraints

Start Over You searched for: Author "Kunnumakkara AB" Remove constraint Author: "Kunnumakkara AB"
192 results on '"Kunnumakkara AB"'

Search Results

1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

2. Synergistic enhancement: Exploring the potential of piperine in cancer therapeutics through chemosensitization and combination therapies.

3. Tackling exosome and nuclear receptor interaction: an emerging paradigm in the treatment of chronic diseases.

4. Harnessing potential role of gangliosides in immunomodulation and cancer therapeutics.

5. The emerging role of human papillomavirus in lung cancer.

6. Unlocking the potential of Berberine: Advancing cancer therapy through chemosensitization and combination treatments.

8. Nuclear receptors in ovarian cancer: changing paradigms in cancer therapeutics.

9. Antistress and Antiaging Potentials of Alpha-Lipoic Acid: Insights from Cell Culture-Based Experiments.

10. Natural Prenylflavones from the Stem Bark of Artocarpus altilis : Promising Anticancer Agents for Oral Squamous Cell Carcinoma Targeting the Akt/mTOR/STAT-3 Signaling Pathway.

11. Natural compounds targeting YAP/TAZ axis in cancer: Current state of art and challenges.

12. Targeted inhibition of colorectal cancer proliferation: The dual-modulatory role of 2,4-DTBP on anti-apoptotic Bcl-2 and Survivin proteins.

13. Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics.

14. Lipid metabolism and its implications in tumor cell plasticity and drug resistance: what we learned thus far?

16. Resveratrol as sensitizer in colorectal cancer plasticity.

17. Delineating the role of nuclear receptors in colorectal cancer, a focused review.

18. Therapeutic potential of tocotrienols as chemosensitizers in cancer therapy.

19. Exploring the nexus of nuclear receptors in hematological malignancies.

20. Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review.

21. Scirpusin B isolated from Passiflora edulis Var. flavicarpa attenuates carbohydrate digestive enzymes, pathogenic bacteria and oral squamous cell carcinoma.

22. Crosstalk between Non-Coding RNAs and Wnt/β-Catenin Signaling in Head and Neck Cancer: Identification of Novel Biomarkers and Therapeutic Agents.

23. Exosomal noncoding RNA-mediated spatiotemporal regulation of lipid metabolism: Implications in immune evasion and chronic inflammation.

24. Curcumin, inflammation, and neurological disorders: How are they linked?

25. Natural compounds targeting nuclear receptors for effective cancer therapy.

26. Calebin A targets the HIF-1α/NF-κB pathway to suppress colorectal cancer cell migration.

27. RNPS1 functions as an oncogenic splicing factor in cervical cancer cells.

28. Repurposing FDA-approved drugs as FXR agonists: a structure based in silico pharmacological study.

29. Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?

30. Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials.

31. Targeting Autophagy Using Long Non-Coding RNAs (LncRNAs): New Landscapes in the Arena of Cancer Therapeutics.

32. Resveratrol Modulates Chemosensitisation to 5-FU via β1-Integrin/HIF-1α Axis in CRC Tumor Microenvironment.

34. Nanoparticles in the diagnosis and treatment of cancer metastases: Current and future perspectives.

35. The Journey of Resveratrol from Vineyards to Clinics.

36. A compilation of bioinformatic approaches to identify novel downstream targets for the detection and prophylaxis of cancer.

37. Betulinic acid: A natural promising anticancer drug, current situation, and future perspectives.

38. Unraveling the Potential Role of NEDD4-like E3 Ligases in Cancer.

39. Modulation of diverse oncogenic signaling pathways by oroxylin A: An important strategy for both cancer prevention and treatment.

40. Targeting PD-1/PD-L1 axis as new horizon for ovarian cancer therapy.

41. Demystifying the Functional Role of Nuclear Receptors in Esophageal Cancer.

42. Multifunctionality of Calebin A in inflammation, chronic diseases and cancer.

43. Oroxylin A: A Promising Flavonoid for Prevention and Treatment of Chronic Diseases.

44. The multifaceted role of STAT3 pathway and its implication as a potential therapeutic target in oral cancer.

45. Nuclear receptors in oral cancer-Emerging players in tumorigenesis.

46. Differential Expression of Genes Regulating Store-operated Calcium Entry in Conjunction With Mitochondrial Dynamics as Potential Biomarkers for Cancer: A Single-Cell RNA Analysis.

47. Targeting Nuclear Receptors in Lung Cancer-Novel Therapeutic Prospects.

48. Modulation of Inflammation by Plant-Derived Nutraceuticals in Tendinitis.

49. Wogonin and its analogs for the prevention and treatment of cancer: A systematic review.

50. An overview of the pharmacological activities of scopoletin against different chronic diseases.

Catalog

Books, media, physical & digital resources